Trial intelligence / Profile preview

Nutropin AQ for Growth Restriction in Children with Cystic Fibrosis

NCT00079742Phase 2Completed

Sponsor
Genentech
Start
Sep 2003
Modality
Hormone, rProtein (Recombinant Protein), Biologic
01

Overview

A Phase 2 trial of somatropin in intrauterine growth restriction (IUGR), sponsored by Genentech. Started Sep 2003; status: completed.

02

Drugs

somatropin
03

Conditions

intrauterine growth restriction (IUGR)

Beyond the preview

Go deeper on NCT00079742.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00079742.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call